Oracle Health and Life Sciences Summit registration is open!

Register now. September 9–11, 2025, Orlando, Florida

Seema Verma

Executive Vice President and General Manager of Oracle Health and Life Sciences

Seema Verma is the Executive Vice President and General Manager, Oracle Health and Life Sciences, where she has responsibility of Oracle's EHR (former Cerner) business as well as clinical trials and the health insurance portfolio. She also is a Director on the Board of Lifestance, a public company focused on behavioral health. In addition, she serves on the Board of the USC Price School Board of Councilors.

Before coming to Oracle, she served as a Senior Advisor to private equity firms TPG and Cressey & Co, serving on the Cressey Distinguished Executive Committee. She also served on the Board of Directors for Lumeris, Monogram, Wellsky, ClaimsXten, and ShiftKey. Additionally, she provided advisory services to a variety of early stage and large public health care companies, including national payers and technology companies focusing on strategy, value creation, and operations.

Seema was the former administrator of the Centers for Medicare and Medicaid Services (CMS) between 2017-2021. Confirmed by the Senate on a bi-partisan basis, she had one of the longest terms in modern CMS history. In this role, she oversaw a 1ドル.4 trillion dollar budget and coverage for 145 million beneficiaries. She was responsible for federal policy and operations of Medicare, Medicaid, Health Insurance Exchanges, the Centers for Medicare & Medicaid Innovation (CMMI), and all federal quality and safety regulations. In this role she developed and implemented the federal administration's health care strategic plan across all programs to advance value-based care, innovation, interoperability, and price transparency while reducing drug prices, and regulations through her historic Patients over Paperwork initiative. CMS had numerous accomplishments during her tenure including delivering reduced premiums across Medicare Part D, Medicare Advantage, and individual insurance market as well as addressing the social determinants of health. Her pro-market policies advanced market competition, provided 35ドル insulin to seniors and advanced site neutral payments. Her leadership on the White House COVID Task Force led to the widespread adoption of telehealth, Hospital at Home, and no cost vaccines for the entire country.

Prior to her role at CMS, she founded and sold a national consulting company and worked as a VP for Policy and Planning for a public hospital, public health department, and health system.

In 2019, Seema was named as Modern Healthcare's #1 Most Influential Person in Healthcare and was part of the Top 25 Women Leaders. Her healthcare articles have been published in The Wall Street Journal, Washington Post, Health Affairs, Modern Healthcare, Newsweek, CNN, USA Today, STAT, and others. She is a graduate of the University of Maryland, and John's Hopkins University School of Public Health.

View Seema Verma sessions

Mike Sicilia

Executive Vice President and General Manager, Oracle Health and Life Sciences

An expert in industry cloud solutions, Sicilia is responsible for research and development, go-to-market strategies, and overall operations for Oracle’s industry business units. These units help distinct markets including retail, financial services, communications, healthcare, life sciences, hospitality, engineering and construction, food and beverage, local government, and energy and water solve their most complex business challenges.

In previous roles at Oracle, Sicilia held development and business management leadership responsibilities in the industry business units.

Prior to joining Oracle, Sicilia worked at Primavera Systems (acquired by Oracle in 2008), He joined the development team in 1993, where he worked as a software engineer. In 2006, he was named Primavera’s chief technology officer. As CTO, he set the technology direction for products and managed the global development team. Sicilia also led the technical and due diligence team that worked through the Oracle acquisition.

Sicilia has a BS in computer science from Saint Joseph’s University. He is a board member for the Friends of Father Judge High School where he assists in fundraising efforts for improvements and academic programs at his alma mater. He also works closely with Oracle’s Diversity and Inclusion team to create academic opportunities and career paths in technology for underrepresented groups. As part of that work, Sicilia helped spearhead an Oracle-led scholarship fund for Meharry Medical College School of Applied Computational Sciences.

View Mike Sicilia sessions

Alaa "AJ" Adel

Senior Vice President, Oracle Health International

Alaa Adel (AJ) is the Senior Vice President and Managing Director of Oracle Health & Life Sciences International, leading the global business and driving customer delivery excellence and growth across global markets in Europe, Middle East, Africa, Asia, Australia and Latin America. AJ empowers a diverse team of 2,000+ trusted professionals dedicated to the digital transformation of healthcare and to delivering lasting value to caregivers, people and populations across an expanding international network. Previously, AJ was the Vice President and Managing Director of Oracle Health Middle East and Africa leading a team of General Managers working closely with global clients. His impact on clients and Oracle Health was evident through the leadership of his team to be trusted partners and helping partner organizations achieve their goals and objectives. AJ joined Oracle Cerner in 2009 and held various roles within the company in multiple regions. He spent seven years in the United States of America as the leader of the CommunityWorks organization, where he made a significant contribution to the organization’s growth and success. Prior to joining Oracle Cerner, he held different roles in healthcare leadership at GE and Fuji Medical. During his time at Oracle Health and Life Sciences International, AJ has contributed to the success of multiple countrywide and regionwide mega healthcare projects across the globe. He led the growth of Oracle Health in new countries while also managing existing strategic clients and leading the Oracle Health and Life Sciences International team. Through strong commitment and hard work, AJ spearheaded the addition of the first Oracle Health client to successfully achieve HIMSS Stage 7 outside of the United States and continues to lead on many fronts with the same determination to advance Oracle Health and Life Sciences’ name and those of its clients in the global arena. Under AJ’s leadership, Oracle Health was named Best in KLAS for Global Acute Care EMR in multiple regions. AJ also received multiple client recognition and leadership awards such as the Forbes Top 50 CEO’s award for Global Meets Local 2021. AJ is a graduate of PSU for Technology, has a Bachelor of Science in bio-medical engineering, and is now finishing his Master of Business Administration degree at Park University. AJ volunteers with service agencies and supports children’s organizations abroad.

View Alaa "AJ" Adel sessions

Stacy Amin

Chief Counsel for Global Health Regulatory and Policy, Oracle Health and Life Sciences

Stacy Amin is Vice President and Chief Counsel for Global Health and Life Sciences Regulatory and Policy at Oracle. Previously, she served as General Counsel of the U.S. Food and Drug Administration, as Senior Counsel to the President in the White House Counsel’s Office, and as Chief Counsel of the Senate HELP Committee. Immediately before joining Oracle, she chaired Morrison Foerster’s global Health and Life Sciences Regulatory & Compliance practice, advising pharma, biotech and medtech clients on their most complex challenges and strategic priorities. She has a J.D. from Harvard Law School and B.A. from George Washington University and clerked on the US Court of Appeals for the 8th Circuit.

View Stacy Amin sessions

Lawrence Tallon

Chief Executive, UK Medicines and Healthcare Products Regulatory Agency

Lawrence became the Chief Executive of the MHRA in April 2025. He joined the Agency at a pivotal time for UK healthcare and life sciences, with the Government setting out its aspirations in the NHS Ten-year Plan and the Life Sciences Sector Delivery Plan, both of which will be enabled by safe, agile and risk-proportionate regulation of medicines, novel treatments and technologies. Lawrence has described his plans for the MHRA to set the gold standard in safety and surveillance, to accelerate access to new medicines and treatments and to make a major contribution to research and innovation in UK life sciences.

Before joining the MHRA, Lawrence spent five years as Deputy Chief Executive at Guy’s and St Thomas’ (GSTT) NHS Foundation Trust, one of the largest and most prestigious healthcare provider organizations in the UK. During Covid-19, he secured vital international supplies of medical equipment for the Trust and the wider UK. He led the successful merger of GSTT with the Royal Brompton and Harefield hospitals in 2021, creating a power-house of cardio-respiratory medicine and research. His role included oversight of the organization’s strategy, technology, innovation, commercialization and multiple major strategic change programs.

In the decade prior to that, Lawrence worked in a range of executive strategy and leadership roles in university hospitals in the UK and Middle East. He was Director of Strategy, Planning and Performance at University Hospitals Birmingham, Managing Director of the Shelford Group of UK university hospitals and an Executive Director at Hamad Medical Corporation in Qatar, one of the leading academic medical centers in the Middle East.

Lawrence began his career working for the UK Government in Whitehall, as a fast stream civil servant at the Department of Health and Social Care, before working for the Secretary of State for Health and running the headquarters of the NHS Chief Executive. He worked on a range of high profile national policy issues, working across government and with No.10 Downing Street, Her Majesty’s Treasury and the Cabinet Office, and becoming a senior civil servant within the Department of Health and Social Care.

He holds Bachelor’s and Master’s degrees in History from the School of Oriental and African Studies in London, and a Master’s degree in Global Health Policy from Imperial College London. He is a fellow of the Sciana Network of European health leaders.

View Lawrence Tallon sessions

Patrick Conway

CEO, Optum

Dr. Conway was named CEO of Optum in 2025. Optum has 300K employee team members who serve over 127 million people with annual revenue exceeding 250ドル billion. It includes three main business units. Optum Health, with nearly 90,000 doctors and other clinicians, delivers clinical care and services in clinics, homes, ambulatory surgical centers, behavioral health, and other settings across the country and serves payers, large employers and the government. Optum Rx serves over 62 million people providing pharmacy care services and over 1.6 billion prescriptions per year. Optum Insight is a data and technology business that serves payers, health systems, life sciences, and others across the country. Collectively, Optum delivers health care services to help make the health system better for everyone.

Previously, Patrick served as chief executive officer of Optum Rx. In this role, he led an integrated pharmacy care services organization that is making drugs more affordable and creating a better experience for consumers, filling more than 1.6 billion retail, mail and specialty drug prescriptions annually. He joined Optum in February 2020 and previously served as the chief executive officer of Care Solutions, where he led a portfolio of care continuum businesses serving over 70 million people across acute and post-acute care, care in the home in-person and virtually, mental and behavioral care benefits and delivery, broad population and complex disease health management, specialty care and government health services.

Dr. Conway was president and chief executive officer of Blue Cross and Blue Shield of North Carolina from 2017-19. From 2011 to 2017, he served as Deputy Administrator for Innovation and Quality at the Centers for Medicare and Medicaid Services and as director of the Center for Medicare and Medicaid Innovation and the agency’s Chief Medical Officer. Before joining CMS, he oversaw clinical operations and quality improvement at Cincinnati Children’s Hospital Medical Center.

Dr. Conway is a practicing pediatric hospitalist. He was elected to the National Academy of Medicine in 2014, received the President’s Senior Executive Distinguished Service Award, and was a White House Fellow from 2007 to 2008. He earned his MD with high honors from Baylor College of Medicine, residency training at Boston Children’s Hospital, and Master of Science in clinical epidemiology from the University of Pennsylvania.

View Patrick Conway sessions

Stephanie Conners

CEO, BayCare Health System

Stephanie D. Conners, is president and CEO of BayCare Health System, West Central Florida’s leading health care provider. An experienced executive with over 30 years’ experience in health care, she has built a reputation as an inspiring leader and collaborator committed to health care delivery with the highest standards of clinical excellence, compassion, safety, service and engagement.

That unique combination derives from a career that began at the bedside as a nurse and then moved into patient services before becoming a Chief Nursing Officer. She later added operations to her portfolio and led several high-quality health care systems as the Chief Operating Officer for both not-for-profit and for-profit entities in Pennsylvania and New Jersey before joining the not-for-profit BayCare system in August 2022.

Conners serves as a transformative leader at BayCare, where she has strengthened the organization’s position as a top-tier health provider and a vital economic force for the region. She led a corporate restructuring that secures BayCare’s not-for-profit mission and allows it to swiftly adapt in the evolving health care landscape to meet the specific needs of its communities. In 2025, she was instrumental in advancing BayCare’s academic mission by formalizing a strategic collaboration with Northwestern Medicine, including Northwestern University Feinberg School of Medicine. Under Conners’ leadership, BayCare has significantly expanded its graduate medical education and research programs, resulting in BayCare’s St. Joseph’s Hospital being designated a statutory teaching hospital in 2025. The system has a bold trajectory to grow its residents in training from 300 to 650 by 2029, exemplifying Conners’ commitment to shaping the future of medical education in the region. Guided by her vision, BayCare is also investing in specialized clinical institutes, driving innovation and accelerating strategic initiatives that position the system for long-term excellence and community impact.

Conners fosters a culture of success among BayCare’s 33,000 team members who are dedicated to providing high-quality, compassionate care. Recently, BayCare was named a Top Workplace in the USA by Energage and USA Today and recognized by Fortune Magazine as one of the Best Workplaces for Women, reflecting its inclusive culture.

Conners holds a Bachelor of Science in Nursing from Villanova University, an MBA from Eastern University, and she still maintains her registered nursing license. She and her husband, Timothy Conners, have four children and three grandchildren.

View Stephanie Conners sessions

Tomislav Mihaljevic, MD

President and CEO, Cleveland Clinic

Tom Mihaljevic, MD, directs Cleveland Clinic, a globally integrated healthcare system with 23 hospitals and 280 outpatient locations on three continents. He has led Cleveland Clinic and its 83,000 caregivers since January 2018. Dr. Mihaljevic’s vision is to make Cleveland Clinic the best place for care anywhere and the best place to work in healthcare. Under his guidance, Cleveland Clinic has grown substantially, with 15.7 million patient encounters annually and a yearly operating revenue of 16ドル billion. He is expanding the organization’s worldwide reach to improve as many lives as possible, and has significantly increased its commitment to research and to uplifting the communities Cleveland Clinic serves. Dr. Mihaljevic is a native of Croatia and a U.S. citizen. He joined Cleveland Clinic in 2004 as a cardiac surgeon.

View Tomislav Mihaljevic sessions

Richard Gray, MD

CEO, Mayo Clinic in Arizona

Richard J. Gray, M.D., is CEO of Mayo Clinic in Arizona, the No. 1 hospital in the state as ranked by U.S. News & World Report for the last 12 consecutive years. With a vision to transform medicine to connect and cure as the global authority in the care of serious or complex disease, Mayo Clinic in Arizona serves patients from all 50 states and more than 50 countries each year. Dr. Gray provides executive oversight of the Mayo Clinic Center for Digital Health. He is a professor of surgery, and his research focuses on developing less burdensome and better-coordinated treatments to reduce the risk of cancer recurrence. He has published more than 160 research manuscripts. Prior to being appointed CEO in 2019, Dr. Gray worked as a surgical oncologist and served in leadership roles in the Mayo Clinic Comprehensive Cancer Center and the Department of Surgery. In 2013, he was recognized as the Mayo Clinic Distinguished Educator.

Dr. Gray graduated cum laude from Lake Superior State University and earned his medical degree from the College of Human Medicine at Michigan State University. He came to Mayo Clinic in Arizona in 1995 as a surgical resident. After a fellowship in surgical oncology as a Mayo Clinic Scholar at the H. Lee Moffitt Cancer Center, he joined the Mayo Clinic staff in 2001. He serves on several boards including those of the Arizona Commerce Authority, the Arizona Hospital and Healthcare Association, and Greater Phoenix Leadership. He and his wife, Kathryn, have three sons.

View Richard Gray sessions

Harlan Levine, MD

President, Health Innovation and Policy, City of Hope

Harlan Levine, M.D., is president of health innovation and policy for City of Hope. He also serves as the chairman of the board of AccessHope, a spinout company from City of Hope that is focused on serving the employer market and making leading-edge cancer care available to all regardless of geographical location.

Prior to City of Hope, Dr. Levine held executive roles at UnitedHealth Group, Towers Watson and Anthem Inc. He currently serves as a board member for BioScienceLA, Reimagine Health, Active Life Scientific and Vida Health, and in an advisory capacity for Quantum Health and Laguna Health. In addition, he is a member of the Accessibility and Affordability Working Group for California Institute for Regenerative Medicine, a board trustee for Keck Graduate Institute and a senior fellow for Health Evolution.

He is certified by the American Board of Internal Medicine and licensed by the Medical Board of California. He earned his undergraduate degree from Harvard College and his medical degree from the University of California, San Francisco. He interned at Mount Zion Hospital and Medical Center in San Francisco and completed his residency in internal medicine at Cedars-Sinai Health System in Los Angeles.

Thomas Laur

Chief Executive Officer, DNAnexus

Thomas brings over 25 years of international experience focused on driving growth and innovation for software, data and services companies in the healthcare and life sciences space. Prior to DNAnexus, Thomas was EVP and President at Change Healthcare (NASDAQ: CHNG). Before that, Thomas was President of the global health sciences division at SAP. Previously, Thomas was CEO of Sutherland Healthcare Solutions, and he also worked at Cognizant, as Managing Director responsible for a portfolio of healthcare ventures. Thomas started his career at Deloitte Consulting, where he focused on strategy, transformation, and merger & acquisition programs for technology companies. He received his Master in Business Management degree from the ICHEC Brussels Management School in Brussels, Belgium.

September 9

September 10

September 11